x
Filter:
Filters applied
- Editorials
- EditorialRemove Editorial filter
- Ventura, Hector ORemove Ventura, Hector O filter
- DaSilva-deAbreu, AdrianRemove DaSilva-deAbreu, Adrian filter
- 2021 - 2023Remove 2021 - 2023 filter
Editorials
2 Results
- Editorial
Trends in Heart Failure Outcomes From a Large, Geographically Diverse Cohort During the COVID-19 Pandemic
Mayo Clinic ProceedingsVol. 98Issue 1p4–6Published online: November 20, 2022- Christian C. Faaborg-Andersen
- Adrian daSilva-deAbreu
- Hector O. Ventura
Cited in Scopus: 0The evolving coronavirus disease 2019 (COVID-19) pandemic has presented extraordinary challenges to the health of populations globally. As our understanding of the virus continues to grow at a rapid pace, it has become increasingly clear that the clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection range widely and are in large part dictated by age, underlying comorbidities, and vaccination status. Robust epidemiologic data during the past years have underscored that individuals with chronic health conditions including cardiovascular disease, diabetes mellitus, immunosuppression, tobacco use, and obesity carry a significantly greater risk of falling critically ill with SARS-CoV-2. - Editorial
Understanding Heart Failure Risk in a Diverse Cohort With Human Immunodeficiency Virus Infection
Mayo Clinic ProceedingsVol. 97Issue 3p433–435Published in issue: March, 2022- Christian Faaborg-Andersen
- Adrian daSilva-deAbreu
- Hector O. Ventura
Cited in Scopus: 0After 4 decades of study and numerous therapeutic advancements, human immunodeficiency virus (HIV) infection can today be considered and managed as a chronic disease, and in some parts of the world, the life expectancy of persons living with HIV (PWHs) is comparable to that of persons living without such infection.1 Since it was discovered in the early 1980s, HIV has been known to affect the heart. As PWHs are living longer, their burden of cardiovascular disease (CVD) and their clinical relevance have grown, raising important questions about the pathophysiologic process through which the HIV affects the heart despite optimal treatment with antiretroviral therapy (ART).
